The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...

Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...

Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...

A clean indoor environment can help reduce exposure to pollution. “Use an air purifier with a HEPA filter and seal windows ...

If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...

Respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and lung cancer, ...

Previous non-experimental studies suggest an association between paracetamol exposure in the first year of life and subsequent asthma and eczema developing in childhood; however, randomised trials are ...

Abstract: Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death worldwide and is often accompanied by comorbidities. Patients, due to their health condition, may experience ...

Women face a higher risk of lung damage compared to men, even if they have never smoked. Research shows that biological differences and smaller lung capacity make women more vulnerable to respiratory ...

The standard of care for chronic spontaneous urticaria (CSU) is a step-wise approach with antihistamines, escalating to biologic therapy and ciclosporin in the event of inadequate response. However, ...